Skip to main content
. 2017 Mar 6;174(9):809–821. doi: 10.1111/bph.13739

Table 2.

Combined effects of AZD6244 and linagliptin on podocyte growth

pIC50
[Linagliptin] (nM) Y P Y O
5.2 5.2
1 5.2 5.3
10 5.2 5.1
100 5.2 5.3

Immortalized human podocytes were exposed to vehicle alone, AZD6244 or AZD6244 + linagliptin for 5 days, then cell growth was evaluated. Data are the mean ± SEM of five experiments run in duplicate for each experimental group.